市场调查报告书
商品编码
1403462
2030 年微型冷冻离心机市场预测:按类型、应用和地区分類的全球分析Micro Refrigerated Centrifuge Market Forecasts to 2030 - Global Analysis By Type (Floor-standing and Desktop), Application (Clinical Laboratories, Pharmaceuticals, Agricultural Research and Other Applications) and By Geography |
根据 Stratistics MRC 的数据,在预测期内,全球微型冷冻离心机市场的复合年增长率为 3.2%。
微型冷冻离心机是一种专门的实验室设备,设计用于在控制温度环境的同时透过离心力分离小体积的生物样品。该设备在分子生物学、生物化学和临床诊断等多种应用中至关重要。此离心机使样品高速旋转,以分离不同密度的颗粒和成分。适用于小样品的控温处理,结果准确可靠。
自动化系统可以同时处理大量样品,从而缩短实验和诊断程序的周转时间。这在临床诊断等时间敏感的应用中尤其重要,在这些应用中快速获得结果对于患者护理至关重要。此外,自动化最大限度地减少了人工工作量,降低了人为错误的风险,并确保多次运行的性能一致。这是科学研究的关键要素,正在推动该市场的扩张。
高昂的初始成本是一个挑战,特别是对于预算和资金有限的实验室和研究设施。此外,这也将影响潜在买家的投资收益(ROI)计算,导致这些离心机的生产和市场开拓成本更高,导致采购价格更高,进而阻碍市场成长。
机器人技术的创新在实现精确的样品处理和加工方面发挥关键作用。先进的感测器技术提高了离心过程的精确度,确保在 DNA/RNA 萃取和蛋白质精製等应用中获得最佳结果,并有助于产生高品质、高度可重复的资料。此外,与实验室资讯系统 (LIS) 和资料管理软体连接等智慧技术的整合可简化工作流程并促进离心机操作的即时监控,从而推动市场成长。
缺乏标准化协定和介面使资料管理和通讯变得复杂。不同製造商的离心机型号在设计、尺寸和规格方面可能有所不同,这使得整合到自动化系统中变得困难。此外,由于不相容,实验室无法在不对自动化设定进行重大修改或重新配置的情况下轻鬆更换或升级离心机。这会导致互通性问题并阻碍市场。
COVID-19的爆发对微型冷冻离心机自动化市场产生了负面影响,影响了该行业的需求和供应双方。由于实验室运作和研究活动在封锁和限制期间受到干扰,设备采购和升级放缓。此外,预算限制和优先事项的变化推迟了对自动化技术的投资。这限制了实验室投资具有自动化功能的最先进的微型冷冻离心机的能力,这严重阻碍了市场规模。
由于设计用于实验室桌上型的紧凑而高效的离心机系统,桌上型细分市场预计将占据最大份额。这些离心机具有占地面积小、用户友好的功能、先进的控制系统和可编程功能,可简化和自动化离心过程。此外,这些自动化桌上型离心机特别适用于样品製备、核酸萃取、蛋白质精製等应用,促进了该领域的扩展。
预计临床实验室产业在预测期内的复合年增长率最高。这些离心机专为满足诊断实验室和医疗机构的严格要求而设计。自动化功能包括可程式协定、触控萤幕介面以及与实验室资讯系统的整合。此外,这些进步有助于标准化、高通量样品处理,使临床实验室能够准确、一致地处理大量样品,从而推动该领域的成长。
由于对用于高效和自动化样品处理的先进实验室设备的需求不断增长,欧洲在预测期内占据了最大的市场占有率。该地区致力于创新和优化分子生物学、生物化学和临床诊断等多种应用的实验室工作流程,此类研究将主导该地区在科学研究和医疗保健方面发挥协同作用。位置。
预计北美在预测期内的复合年增长率最高。这些离心机旨在有效处理小体积样品,同时结合自动化功能以提高准确性并优化工作流程。 Kubota Corporation、Nikkei Electro、Accel Sekai 和 Thermo Scientific 等主要公司已向该地区扩张。此外,具有自动化功能的微型冷冻离心机对于研究机构、製药公司和临床实验室至关重要,可推动该地区的成长。
According to Stratistics MRC, the Global Micro Refrigerated Centrifuge Market is at a CAGR of 3.2% during the forecast period. A micro refrigerated centrifuge is a specialized laboratory instrument designed for the separation of small volumes of biological samples through centrifugal force while also maintaining a controlled temperature environment. This device is crucial in various applications, particularly in molecular biology, biochemistry, and clinical diagnostics. This centrifuge operates by spinning samples at high speeds, causing particles or components with different densities to separate. It is suitable for handling small sample volumes with temperature control, ensuring accurate and reliable results.
Automated systems can handle a higher volume of samples concurrently, reducing turnaround times for experiments and diagnostic procedures. This is particularly crucial in time-sensitive applications, such as clinical diagnostics, where rapid results are essential for patient care. Moreover, automation minimizes manual intervention, reducing the risk of human errors and ensuring consistent performance across multiple runs contributing to the reproducibility of results, a crucial factor in scientific research which are boosting this market expansion.
The high initial costs pose a challenge for laboratories and research facilities, particularly those with limited budgets or funding constraints, which could discourage prospective purchasers from implementing automation in their processes. Moreover, this also impacts the return on investment (ROI) calculations for potential buyers, and consequently, the manufacturing and development costs of these centrifuges are high, leading to elevated purchase prices that are impeding market growth.
Innovations in robotics play a crucial role in enabling precise sample handling and processing. Advanced sensor technologies enhance the accuracy of centrifugation processes, ensuring optimal results in applications such as DNA/RNA extraction and protein purification, which contribute to the generation of high-quality, reproducible data. Additionally, integration with smart technologies, such as connectivity with laboratory information systems (LIS) and data management software, streamlines workflows and facilitates real-time monitoring of centrifuge operations, thereby driving market growth.
The absence of standardized protocols and interfaces complicates data management and communication. Different manufacturers may employ varying designs, sizes, and specifications for their centrifuge models, making it challenging to integrate them into automated systems. Furthermore, the lack of compatibility prevents laboratories from easily swapping or upgrading centrifuges without significant modifications or reconfiguration of the automation setup. This can lead to interoperability issues and hinder the market.
The COVID-19 pandemic has had negative impacts on the micro-refrigerated centrifuge automation market, affecting both demand and supply aspects of the industry. The disruptions in laboratory operations and research activities during lockdowns and restrictions have led to a slowdown in equipment purchases and upgrades. Furthermore, budget constraints and shifting priorities have resulted in postponed investments in automation technologies. This has limited the ability of laboratories to invest in new and advanced micro-refrigerated centrifuges with automation features, which has significantly hampered the market size.
The desktop segment is estimated to hold the largest share due to compact and efficient centrifuge systems designed for use on laboratory desktops. These centrifuges are characterized by their smaller footprint and user-friendly features, advanced control systems, and programmable functionalities that streamline and automate centrifugation processes. In addition, these automated desktop centrifuges are particularly used in applications such as sample preparation, nucleic acid extraction, and protein purification, which are boosting this segment's expansion.
The clinical laboratories segment is anticipated to have highest CAGR during the forecast period. These centrifuges are specifically designed to meet the stringent requirements of diagnostic laboratories and medical facilities. Automation features may include programmable protocols, touch-screen interfaces, and integration with laboratory information systems. Furthermore, these advancements contribute to standardized and high-throughput sample processing, allowing clinical laboratories to handle a large volume of samples with precision and consistency, which is driving this segment's growth.
Europe commanded the largest market share during the extrapolated period, owing to a growing demand for advanced laboratory equipment designed for efficient and automated sample processing. These advancements are led by the region's emphasis on technological innovation and a commitment to optimizing laboratory workflows with diverse applications, including molecular biology, biochemistry, and clinical diagnostics, aligning with the region's prominent position in scientific research and healthcare.
North America is expected to witness highest CAGR over the projection period. These centrifuges are designed to handle small sample volumes efficiently while incorporating automation for improved precision and workflow optimization. This region is home to some of the major players, including Kubota Corporation, Nicke-Electro Ltd., Axel Global, and Thermo Scientific. In addition, microrefrigerated centrifuges with automation features are integral to research institutions, pharmaceutical companies, and clinical laboratories, which are driving the growth of this region.
Some of the key players in the Micro Refrigerated Centrifuge Market include Axel Global, Benchmark Scientific, Inc., Eppendorf AG, Esco Scientific, Gyrozen, Hermle Labortechnik GmbH, Hitachi Koki Co., Ltd., Kubota Corporation, lab Force, Nicke-Electro Ltd., Sartorius AG, Scilogex and Thermo Scientific.
In December 2023, Thermo Fisher Scientific Inc. announced a new partnership to improve the wellbeing and treatment outcomes of adolescents and young persons living with HIV in Nigeria, the country with the second largest HIV epidemic worldwide.
In July 2023, A new benchmark has launched to bring more clarity to the definition of a high-quality carbon credit, which companies are increasingly using to offset their climate impact.
In May 2023, Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency of Indonesia (BRIN, Badan Riset dan Inovasi Nasional) to enable and enhance the country's national research and innovation infrastructure and capability.